Want to join the conversation?
$CELG 2Q15 PR: FY15 Guidance: Total net product sales will be in the range of $9.0Bil to $9.5Bil.REVLIMID net sales will be in the range of $5.6Bil $5.7Bil. ABRAXANE net sales will be in the range of $1.0Bil to 1.25Bil. Adjusted diluted EPS will be in the range of $4.75 $4.85. GAAP diluted EPS will be in the range of $2.17 to $2.46.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!